William Pelham to Psychiatric Status Rating Scales
This is a "connection" page, showing publications William Pelham has written about Psychiatric Status Rating Scales.
Connection Strength
1.249
-
Sibley MH, Waxmonsky JG, Robb JA, Pelham WE. Implications of changes for the field: ADHD. J Learn Disabil. 2013 Jan-Feb; 46(1):34-42.
Score: 0.411
-
Breaux R, Babinski DE, Willoughby MT, Haas SM, Coles EK, Pelham WE, Waxmonsky JG, Waschbusch DA. Examining Psychopathic Traits in Children Using the Child Psychopathy Scale - Revised. J Abnorm Child Psychol. 2020 02; 48(2):251-263.
Score: 0.170
-
Babinski DE, Waxmonsky JG, Waschbusch DA, Humphery H, Pelham WE. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 Apr; 27(3):250-257.
Score: 0.137
-
Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, Abikoff H, Hinshaw SP, Molina BSG, Mitchell JT, Jensen PS, Howard AL, Lakes KD, Pelham WE. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun; 58(6):655-662.
Score: 0.134
-
Lahey BB, Pelham WE, Loney J, Lee SS, Willcutt E. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry. 2005 Aug; 62(8):896-902.
Score: 0.062
-
Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol. 2005 May; 13(2):111-26.
Score: 0.061
-
Lahey BB, Pelham WE, Loney J, Kipp H, Ehrhardt A, Lee SS, Willcutt EG, Hartung CM, Chronis A, Massetti G. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry. 2004 Nov; 161(11):2014-20.
Score: 0.059
-
Baweja R, Belin PJ, Humphrey HH, Babocsai L, Pariseau ME, Waschbusch DA, Hoffman MT, Akinnusi OO, Haak JL, Pelham WE, Waxmonsky JG. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. J Child Adolesc Psychopharmacol. 2016 Mar; 26(2):154-63.
Score: 0.032
-
Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):250-63.
Score: 0.026
-
Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010 Nov; 71(11):1535-51.
Score: 0.022
-
Shiels K, Hawk LW, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE, Waxmonsky JG, Gangloff BP. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2009 Oct; 17(5):291-301.
Score: 0.021
-
King S, Waschbusch DA, Pelham WE, Frankland BW, Corkum PV, Jacques S. Subtypes of aggression in children with attention deficit hyperactivity disorder: medication effects and comparison with typical children. J Clin Child Adolesc Psychol. 2009 Sep; 38(5):619-29.
Score: 0.021
-
Kaiser NM, Hoza B, Pelham WE, Gnagy E, Greiner AR. ADHD status and degree of positive illusions: moderational and mediational relations with actual behavior. J Atten Disord. 2008 Nov; 12(3):227-38.
Score: 0.019
-
Marshal MP, Molina BS, Pelham WE, Cheong J. Attention-deficit hyperactivity disorder moderates the life stress pathway to alcohol problems in children of alcoholics. Alcohol Clin Exp Res. 2007 Apr; 31(4):564-74.
Score: 0.017
-
Molina BS, Pelham WE, Gnagy EM, Thompson AL, Marshal MP. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res. 2007 Apr; 31(4):643-54.
Score: 0.017
-
Lahey BB, Pelham WE, Chronis A, Massetti G, Kipp H, Ehrhardt A, Lee SS. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. J Child Psychol Psychiatry. 2006 May; 47(5):472-9.
Score: 0.016
-
Rieppi R, Greenhill LL, Ford RE, Chuang S, Wu M, Davies M, Abikoff HB, Arnold LE, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):269-77.
Score: 0.012
-
Smith BH, Pelham WE, Gnagy E, Molina B, Evans S. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2000 Jun; 68(3):489-499.
Score: 0.011